Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism LRP1 modulators(LDL receptor related protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization Novoron Bioscience, Inc.Startup |
Active Organization Novoron Bioscience, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
acute spinal cord injury | Discovery | US | Novoron Bioscience, Inc.Startup | 20 Jul 2020 |
Multiple Sclerosis | Discovery | US | Novoron Bioscience, Inc.Startup | 20 Jul 2020 |
Tauopathies | Discovery | US | Novoron Bioscience, Inc.Startup | 20 Jul 2020 |
Alzheimer Disease | Discovery | US | Novoron Bioscience, Inc.Startup | - |
Brain Injuries, Traumatic | Discovery | US | Novoron Bioscience, Inc.Startup | - |
Glaucoma | Discovery | US | Novoron Bioscience, Inc.Startup | - |